AGILE: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Combination with Azacitidine in Adult Patients with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

被引:7
|
作者
Montesinos Fernandez, Pau [1 ]
Recher, Christian [2 ,3 ]
Doronin, Vadim [4 ]
Calado, Rodrigo T. [5 ]
Jang, Jun Ho [6 ]
Miyazaki, Yasushi [7 ]
Wang, Jianxiang [8 ]
Gianolio, Diego A. [9 ]
Daigle, Scott R. [9 ]
Winkler, Thomas [9 ]
Zhang, Vickie [9 ]
Paschka, Peter [10 ]
机构
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Toulouse, France
[3] Univ Toulouse III, Toulouse, France
[4] City Clin Hosp 40, St Petersburg, Russia
[5] Univ Sao Paulo, Ribeirao Preto Sch Med, Sao Paulo, Brazil
[6] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[7] Nagasaki Univ Hosp, Atom Bomb Dis Inst, Nagasaki, Japan
[8] Peking Union Med Coll, Inst Hematol Hosp Blood Dis, Beijing, Peoples R China
[9] Agios Pharmaceut Inc, Cambridge, MA USA
[10] Univ Ulm, Ulm, Germany
关键词
D O I
10.1182/blood-2019-123045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2593
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Phase 3, randomized, placebo-controlled trials evaluating glasdegib in combination with intensive or nonintensive chemotherapy in patients with untreated acute myeloid leukemia.
    Cortes, Jorge E.
    Dombret, Herve
    Merchant, Akil Abid
    Tauchi, Tetsuzo
    DiRienzo, Christine
    Zeremski, Mirjana
    Sleight, Barbara
    Zhang, Xiaoxi
    Shaik, Mohammed Naveed
    Bell, Timothy
    Chan, Geoffrey
    Sekeres, Mikkael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
    Wei, Andrew H.
    Kennedy, Glen A.
    Morris, Kirk L.
    Grigg, Andrew
    He, Simon
    Schwarer, Anthony
    Ting, Stephen B.
    Enjeti, Anoop Kumar
    Yuen, Sam
    D'Rozario, James
    Latimer, Maya
    Marlton, Paula
    Bilmon, Ian
    Taper, John
    Cull, Gavin
    Tiley, Campbell
    Verner, Emma
    Hahn, Uwe H.
    Hiwase, Devendra K.
    Iland, Harry
    Murphy, Nichloas
    Ravanathan, Sundra
    Nguyen, Uyen
    Ong, Doen Ming
    Loo, Sun
    Tiong, Ing-Soo
    Wall, Meaghan
    Anstee, Natasha S.
    Levis, Mark
    Murray, Michael
    Rawling, Tristan
    Leadbetter, Joanna
    Bajel, Ashish
    Roberts, Andrew W.
    BLOOD, 2020, 136
  • [23] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
  • [24] Bosentan therapy in patients with Eisenmenger syndrome - A multicenter, double-blind, randomized, placebo-controlled study
    Galie, Nazzareno
    Beghetti, Maurice
    Gatzoulis, Michael A.
    Granton, John
    Berger, Rolf M. F.
    Lauer, Andrea
    Chiossi, Eleonora
    Landzberg, Michael
    CIRCULATION, 2006, 114 (01) : 48 - 54
  • [25] Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Anderson, Karl
    Balwani, Manisha
    Sardh, Eliane
    Gouya, Laurent
    Rees, David
    Stein, Penelope
    Stolzel, Ulrich
    Aguilera, Paula
    Bissell, D. Montgomery
    Bonkovsky, Herbert
    Keel, Sioban
    Parker, Charles
    Phillips, John
    Silver, Samuel
    Windyga, Jerzy
    D'Avola, Delia
    Ross, Gayle
    Stewart, Peter
    Ritchie, Bruce
    Oh, Jeeyoung
    Harper, Pauline
    Wang, Jiaan-Der
    Langendonk, Janneke
    Ivanova, Aneta
    Horie, Yutaka
    Minder, Elisabeth
    Vassiliou, Daphne
    Kubisch, Ilja
    Guillen-Navarro, Encarna
    Coman, David
    Wang, Bruce
    Kuo, Hung-Chou
    Scalera, Sushama
    Penz, Craig
    Hua, Zoe
    Simon, Amy
    Ko, John J.
    Ventura, Paolo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S578 - S578
  • [26] Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double-blind, placebo-controlled pilot study
    Fang, Xiu Cai
    Lin, Zhi Hui
    Wu, Yong Dong
    Tian, De An
    Liu, Shi
    Wu, Dong Sheng
    Lin, Han
    Meng, Fan Dong
    Liu, Mei
    Du, Fan
    Shu, Hui Jun
    Wang, Zhi Feng
    Zhuo, Jian Min
    Wang, Ping
    Li, Meng Yu
    Xu, Jian
    JOURNAL OF DIGESTIVE DISEASES, 2023, 24 (11) : 603 - 610
  • [27] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)
    Furman, Richard R.
    Sharman, Jeff P.
    Coutre, Steven E.
    Cheson, Bruce D.
    Pagel, John M.
    Hillmen, Peter
    Barrientos, Jacqueline C.
    Zelenetz, Andrew D.
    Kipps, Thomas J.
    Flinn, Ian
    Ghia, Paolo
    Eradat, Herbert
    Ervin, Thomas
    Lamanna, Nicole
    Hallek, Michael
    Coiffier, Bertrand
    Pettitt, Andrew R.
    Ma, Shuo
    Stilgenbauer, Stephan
    Cramer, Paula
    Aiello, Maria
    Johnson, Dave M.
    Miller, Langdon L.
    Li, Daniel
    Jahn, Thomas M.
    Dansey, Roger D.
    O'Brien, Susan M.
    BLOOD, 2013, 122 (21)
  • [28] Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
    Abou-Alfa, Ghassan K.
    Macarulla, Teresa
    Javle, Milind M.
    Kelley, Robin K.
    Lubner, Sam J.
    Adeva, Jorge
    Cleary, James M.
    Catenacci, Daniel V.
    Borad, Mitesh J.
    Bridgewater, John
    Harris, William P.
    Murphy, Adrian G.
    Oh, Do-Youn
    Whisenant, Jonathan
    Lowery, Maeve A.
    Goyal, Lipika
    Shroff, Rachna T.
    El-Khoueiry, Anthony B.
    Fan, Bin
    Wu, Bin
    Chamberlain, Christina X.
    Jiang, Liewen
    Gliser, Camelia
    Pandya, Shuchi S.
    Valle, Juan W.
    Zhu, Andrew X.
    LANCET ONCOLOGY, 2020, 21 (06): : 796 - 807
  • [29] Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study
    Uchimura, Naohisa
    Taniguchi, Mitsutaka
    Ariyoshi, Yu
    Oka, Yasunori
    Togo, Osamu
    Uchiyama, Makoto
    SLEEP MEDICINE, 2024, 122 : 27 - 34
  • [30] SALUTE: a placebo-controlled, double-blind, multicenter, randomized, phase II study of bevacizumab in previously untreated extensive-stage small cell lung cancer (SCLC)
    Spigel, David R.
    Townley, Peter M.
    Waterhouse, David M.
    Fang Liang
    Adiguzel, Ibrahim
    Huang, Jane E.
    Scappaticci, Frank A.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S398 - S398